August 31, 2017

MPM’s Chris Bardon Applauds Novartis’ Value-Based Pricing Move for its CAR-T Cell Therapy Kymriah

Read BioWorld article “Gene therapy, cloaked in cell therapy, arrives in U.S. courtesy of Kymriah”